Singapore Health Sciences Authority Cracks Down on E-Cigarette Black Market

Jul.05.2024
Singapore Health Sciences Authority Cracks Down on E-Cigarette Black Market
Singapore Health Sciences Authority (HSA) seized over 350,000 e-cigarette products worth $6 million in June raids.

According to Channel News Asia's report on July 4th, the Health Sciences Authority (HSA) in Singapore stated that over 350,000 e-cigarette products were seized in raids across the country in June.


The black market value of these e-cigarette products exceeds 6 million Singapore dollars (approximately 4.44 million US dollars) and were originally planned to be sold through Telegram.


The Health Sciences Authority (HSA) confirmed that a series of raids carried out from June 14 to 18 at three separate locations effectively targeted one of Singapore's largest e-cigarette distribution networks.


Authorities received news on June 14 that a large quantity of e-cigarettes and components were found in a warehouse at Woodlands Loop.


Following that, there were two more raids conducted, one at an apartment unit on Guillemard Crescent on the same day, and another at a warehouse unit in the Woodlands industrial park on June 18th. HSA stated that more e-cigarette products were also found at these two locations.


Additionally, 14 e-cigarettes suspected to contain the controlled substance tetrahydrocannabinol (THC) have been discovered, and these products have been handed over to the Central Narcotics Bureau (CNB) for processing. Four men and women, ranging in age from 34 to 52, are currently assisting in the investigations conducted by the Health Sciences Authority (HSA) and CNB.


The Health Sciences Authority (HSA) has reported seizures of e-cigarette products worth over 18 million Singapore dollars (13.32 million US dollars) since January. Authorities have warned that importing, distributing, selling, or advertising e-cigarette products is illegal.


For the first time offenders found importing, distributing, or selling e-cigarette products, they can be fined up to $10,000 (USD 7401), or face imprisonment for a maximum of 6 months, or both. For second-time offenders and beyond, the maximum fine can reach $20,000 (USD 14,802), or imprisonment for up to 12 months, or both. It is illegal to purchase, use, or possess e-cigarettes, with a maximum fine of $2000 (USD 1480).


Last year, Singapore authorities dealt with around 8,000 cases of e-cigarette-related offenses, a 43% increase from the 5,600 cases in 2022. There were a total of 7,600 recorded offenses in 2021.


In December of last year, authorities announced plans to enhance inspections of e-cigarettes and their components at border checkpoints in Singapore. They also stated that they would increase efforts to combat the use of e-cigarettes in "public hotspots.


From January 1 to March 31, it was discovered that over 2200 people were using or in possession of e-cigarettes.


In May this year, Rahayu Mahzam, the Senior Parliamentary Secretary of the Ministry of Health, stated that the Health Sciences Authority is reviewing legal penalties to enhance deterrence against e-cigarette advertising, importation, and distribution.


She added that the Health and Safety Authority has been monitoring illegal e-cigarette sales on social media, e-commerce, and communication platforms, and taking action to remove e-cigarette-related content.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
U.S. nicotine pouch brand Sesh has emphasized its independence from Altria, Philip Morris International and British American Tobacco, along with backing from investors including 8VC, celebrity supporters and a retail footprint of more than 7,500 stores, as it seeks to differentiate itself in a market where major pouch brands are owned by large tobacco companies.
Regulations
Jul.07 by 2Firsts Perspectives
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27